Showing 1 - 1 results of 1 for search 'Rang Gao', query time: 0.02s Refine Results
  1. 1
    AdvanTIG-105: a phase I dose escalation study of the anti-TIGIT monoclonal antibody ociperlimab in combination with tislelizumab in patients with advanced solid tumors

    AdvanTIG-105: a phase I dose escalation study of the anti-TIGIT monoclonal antibody ociperlimab in combination with tislelizumab in patients with advanced solid tumors by Wei Tan, Tarek Meniawy, Steven Kao, Nageshwar Budha, Sophia Frentzas, Hao Zheng, Rang Gao, Ahsan Rizwan, Luz de la Hoz Pedroza

    Published 2023-10-01
    Get full text
    Article

Search Tools: